Poster Set Up
Our poster session will be split into A and B sessions, but we will have everyone pin their poster to the numbered board (front-facing for A and backside for B). This will allow us to flip the boards to switch over the session. Poster boards are standard size, typically found at most conferences (landscape layout by default). Please have your poster ready to setup by the beginning of the poster session, 5 PM on Monday, Dec 1st.
Poster Assignments
| Poster Session A: December 1, 5:25-6:10 pm | ||
|---|---|---|
| Presenter(s) | Project | PI(s) |
| Tom Bamberger | 3D Proteomics at Single-Cell Resolution with Covalent Protein Painting (CPP) | John R. Yates III |
| Amanda Kussrow | Quantification of Molecular Interactions Across the Matrix Spectrum Enables Cancer Research | Darryl J. Bornhop |
| Russell Walton | Profiling and Perturbing the Inheritance of Drug-Induced Metabolic States in Cancer with Inheritance-Seq | Paul C. Blainey |
| Yue Lu | Vesicle Epitope Transcript sequencing (VET-seq): Droplet-Based Multiomic Profiling Platform for Single Vesicle Analysis | Yue Lu |
| Huiqing(Jane) Zhou and Nan Liu | Development of A Directed Evolution Platform for RNA Methyltransferases. | Huiqing(Jane) Zhou, Jia Niu |
| Torsten Wittman | Quantitative Analysis and Manipulation of Chromosome Dynamics in Cancer Organoids | Torsten Wittman |
| Jeff Tza-Huei Wang and Thomas Pisanic II | A Low-Cost, Multiplexed, Digital High-Resolution Melt Platform for DNA Methylation-Based Detection and Identification of Cancers in Liquid Biopsies | Jeff Tza-Huei Wang, Thomas Pisanic II |
| Sebastian Castillo-Hair | Sequence Optimization for mRNA Cancer Therapy | Georg Seelig |
| Manav Jain | Identification of Cancer Neoepitope-Specific T Cells Using Novel High-Throughput Hydrogel Based Platforms | Jonathan Schneck |
| Matthew Shorey | A Multiplexed High-Throughput Platform to Report Pharmacologic Alteration of Cancer Stem Cell Membrane Potential and Cell Cycle State | Robert Rostomily, Francois St-Pierre |
| Sapun Parekh and James Tunnell | Precision Tumor Sampling of Melanoma Using Laser Microbiopsy | Sapun Parekh, James Tunnell |
| Philipp Oberdoerffer | Proximity Epigenomics for Context-Specific Analysis of Complex Chromatin Features | Phillipp Oberdoerffer |
| Jarrod Marto | New Chemical Tools for Covalent Drug Discovery | Jarrod Marto, Justin Kim |
| Jungwoo Lee | Develop and Validate Demineralized Bone Paper-Based Human Bone Metabolic and Senolytic Assays | Jungwoo Lee |
| Tania Konry | Microphysiological Platform for Analyzing Multiple Myelomas Tumor Microenvironment, Enabling Immunotherapy Assessment and Drug Screening | Tania Konry |
| Poster Session B: December 1, 6:15-7 pm | ||
|---|---|---|
| Presenter(s) | Project | PI(s) |
| Andrei Karginov | Mapping Dynamic Changes in Protein Interactome using Proximity Labeling with High Temporal Resolution | Andrei Karginov, Alexander Adibekian |
| Jeffrey Ishizuka | Multiplexed, Continuous Reporting of Gene Expression via CRISPR-Mediated Transcriptional Activation | Jeffrey Ishizuka |
| Hyungsoon Im, Jihye Hong, and Jisun Ki | Nano-CRISPR Extracellular Vesicle Sensing System for Longitudinal Tumor Monitoring | Hyungsoon Im |
| Sarah Heilshorn and Esther Mozipo | Tumor Metabolic Profiling by Multiplexed Single-Cell Lipid and mRNA Imaging | Sarah Heilshorn |
| Wilhelm Haas and Soroush Hajizadeh | A Real-Time AI-Driven High-Throughput Proteomics Data Acquisition Method for Clinical Applications | Wilhelm Haas, Lecia Sequist |
| Timothy Griffin and Pratik Jagtap | An Enabling Approach for Deep Metaproteomic Characterization of Microbial Contributors to Tumorigenesis in Clinical Samples | Timothy Griffin, Ryan Hunter, Pratik Jagtap |
| Yanxiang Deng | Spatially Resolved Multi-Omics Sequencing of FFPE Tissues at Cellular Level | Yanxiang Deng |
| Brian Cunningham | Rapid, Simple, and Ultrasensitive Quantitation of KRAS ctDNA at the Point of Care Using CRISPR/Cas Amplification and Digital Resolution Biosensor Microscopy | Brian Cunningham, Aaron Mansfield, Xing Wang |
| Ahmet Coskun | Spatial Protein-Protein Interaction Networks In Situ by Multiplexed Proximity Ligation | Ahmet Coskun |
| Ji-Xin Cheng | Bio-Orthogonal Mid-Infrared Photothermal Imaging of Cancer Metabolism | Ji-Xin Cheng |
| Fei Chen | A Platform for Multi-Modal Single Nucleus Spatial Genomics for Molecular Tumor Analysis | Fei Chen |
| Joshua Breunig and Alberto Ayala-Sarmiento | Enabling In Vivo Barcoded Single-Cell Multiomics-Compatible Genome-Wide Screens in Personalized Tumor Models Using Defined-Copy Somatic Transgenesis | Joshua Breunig |
| Jesse Boehm | Advanced Development of Patient Ascites Therapeutic Response Biosensors | Jesse Boehm, Beth Cimini, Samuel Klempner |
| Elisa Biondi | Evolved Molecules that Destroy Cancer Relevant Proteins | Elisa Biondi |
| Gloria Sheynkman and Megan Schertzer | An Integrated Functional Proteomics Platform for Accelerated Discovery of Isoform-Specific Determinants of Cancer | Gloria Sheynkman |
Branding on Posters
NOTE: NIH policy requires that NIH/NCI grantees not use government logos such as the NIH Logo and NCI Logo or the IMAT logo on their posters. As the author/presenter of the poster, the appropriate branding on your poster is of your institution; the grant was awarded to your institution.
You should identify your IMAT grant in text, using the following statement:
Funded in part by the National Cancer Institute of the National Institutes of Health, Innovative Molecular Analysis Technologies (IMAT) Program, Grant Number: ____________.
If you are collaborating with an NCI researcher, the NCI Logo still may not be used; that person is to be identified on your poster in the authors' section with “National Cancer Institute, Bethesda, MD” listed as the affiliation, not the NCI logo. The NCI Logo and other NIH/HHS logos are trademarked by HHS and are to be used only when an NCI staff researcher is the author and presenter of a poster.